Fibrosing alveolitis in systemic sclerosis: Indices of lung function in relation to extent of disease on computed tomography

Arthritis and Rheumatism

Volumn 40, Issue 7, 1997, Pages 1229-1236

  Wells, A U ^a   Hansell, D M ^b   Rubens, M B ^b   King, A D ^b   Cramer, D ^b   Black, C M ^b,c   Du Bois, R M ^b  

^a GREEN LANE HOSPITAL   (New Zealand)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; OXYGEN;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

EID: 0030883485     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400706     Document Type: Article

References (50)

1. LeRoy EC: Sentinel signs and symptoms of systemic sclerosis. Curr Opin Rheumatol 1:499-504, 1989
2. Weaver AL, Divertie MB, Titus JL: Pulmonary scleroderma. Dis Chest 54:490-498, 1968
3. D'Angelo WA, Fries JF, Masi AT, Shulman LE: Pathologic observations in systemic sclerosis (scleroderma): a study of 58 autopsy cases and 58 matched controls. Am J Med 46:428-440, 1969
4. Harrison NK, Myers R, Corrin B, Soosay G, Dewar A, Black CM, du Bois RM, Turner-Warwick M: Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 144:706-713, 1991
5. Wells AU, Cullinan P, Hansell DM, Rubens MB, Black CM, Newman-Taylor AJ, du Bois RM: Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 149:1583-1590, 1994
6. Bagg LR, Hughes DTD: Serial pulmonary function tests in progressive systemic sclerosis. Thorax 34:224-228, 1979
7. Lee P, Langevitz P, Alderdice CA, Aubrey M, Baer PA, Baron M, Buskila D, Dutz JP, Khostanteen I, Piper S: Mortality in systemic sclerosis (scleroderma). QJM 82:139-148, 1992
8. Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr: Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 35:765-770, 1992
9. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG: Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298:801-809, 1978
10. Johnson MA, Kwan S, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M: Randomised control trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44:280-288, 1989
11. Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, Hutchinson J, Pardee NE, Winterbauer RH: Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled trial. Am Rev Respir Dis 144:291-296, 1991
12. Wells AU, du Bois RM: Prediction of disease progression in idiopathic pulmonary fibrosis. Eur Respir J 7:637-639, 1994
13. Keogh BA, Crystal RG: Pulmonary function testing in interstitial pulmonary disease: what does it tell us? Chest 78:856-864, 1980
14. Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Polzleitner D, Burghuber OC, Tscholakoff D: Interstitial lung disease in progressive systemic sclerosis: high resolution CT versus radiography. Radiology 176:755-759, 1990
15. Collins CD, Wells AU, Hansell DM, Morgan RA, MacSweeney JE, du Bois RM, Rubens MB: Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol 49:236-240, 1994
16. Subcommittee for Seleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
17. Quanjer PH: Standardised lung function testing. Bull Eur Physiopathol Respir 19 (suppl 5):1-92, 1983
18. Riley RL, Cournand A: Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. J Appl Physiol 1:825-847, 1949
19. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM: A clinical, radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 133:97-103, 1986
20. Kleinbaum DC, Kupper LL, Muller R: Applied Regression Analysis and Other Multivariate Methods. Boston, Kent, 1988
21. Gaensler EA, Carrington CB: Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic and physiological correlations in 502 patients. Ann Thorac Surg 30:411-415, 1980
22. Green GM, Graham WBG, Hanson JS, Gump DW, Phillips CA, Brody AR, Sylvester DW, Landis JN, Davis GS, Craighead JE: Correlated studies of interstitial pulmonary disease (abstract). Chest 69 (suppl 2):263, 1976
23. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG: Usual and desquamative interstitial pneumonia. Chest 69 (suppl 2):261-263, 1976
24. Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron JA, Ackerson L, Schwarz MI, King TE: Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 151:1180-1188, 1995
25. Staples CA, Muller NL, Vedal S, Abboud R, Ostrow D, Miller RR: Usual interstitial pneumonia: correlation of CT with clinical, functional and radiologie findings. Radiology 162:377-381, 1987
26. Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM: Functional impairment in lone cryptogenic fibrosing alveolitis: a correlation based upon extent of disease on thin section computed tomography. Am J Respir Crit Care Med (in press)
27. Muller NL, Miller RR, Webb WR, Evans KG, Ostrow DN: Fibrosing alveolitis: CT-pathologic correlation. Radiology 165: 731-734, 1987
28. Cherniak RM, Colby TV, Flint A, Thurlbeck WM, Waldron J, Ackerson L, King TE, and the BAL Co-operative Group Steering Committee: Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 144:892-900, 1991
29. Ashcroft T, Simpson JM, Timbrell V: Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41:467-470, 1988
30. Webb WR, Müller NL, Naidich TP: High-Resolution CT of the Lung. New York, Raven Press, 1996
31. Murata K, Khan A, Rojas K, Herman PG: Optimization of computed tomography technique to demonstrate the fine structure of the lung. Invest Radiol 23:170-175, 1988
32. Wells AU, Hansell DM, Rubens MB, Cullinan P, Black CM, du Bois RM: The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 148:1076-1082, 1993
33. Muller NL, Mawson JB, Mathieson JR, Abboud R, Ostrow DN, Champion N: Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 171:613-618, 1989
34. Wells AU, Rubens MB, du Bois RM, Hansell DM: Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. Am J Roentacnol 161:1159-1165, 1993
35. Aberle DR, Hansell DM, Brown K, Tashkin DP: Lymphangiomyomatosis: CT, chest radiographic and functional correlations. Radiology 176:381-387, 1990
36. Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, du Bois RM: High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 47:738-742, 1992
37. Rienmuller RK, Behr J, Kalendar WA, Schatzl M, Altmann I, Merin M, Beinert T: Standardised quantitative high resolution CT in lung diseases. J Comput Assist Tomogr 15:742-749, 1991
38. Lynch DA, Moxley D, Newell JD, Raff U, King TE: Idiopathic pulmonary fibrosis: correlation between CT measures of disease extent and pulmonary physiologic abnormality (abstract). Am J Respir Crit Care Med 149:A281, 1994
39. Muller NL, Staples CA, Miller RR, Abboud RT: "Density mask": an objective method to quantitate emphysema using computed tomography. Chest 94:782-787, 1988
40. Sehneider PD, Wise RA, Hochberg MC, Wigley FM: Serial pulmonary function in systemic sclerosis. Am J Med 73:385-394, 1982
41. Peters-Golden M, Wise RA, Hochberg MC, Stevens MB, Wigley FM: Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med 77:1027-1034, 1984
42. Greenwald GI, Tashkin DP, Gong H, Simmons M, Duann S, Furst DE, Clements P: Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Am J Med 83:83-92, 1987
43. Steen VD, Conte C, Owen GR, Medsger TA Jr: Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37:1283-1289, 1994
44. 99mTc-DTPA clearance. Respir Med 83:403-414, 1989
45. Watanuki Y, Suzuki S, Nishikawa M, Miyashita A, Okubo T: Correlation of quantitative CT with selective alveolobronchogram and pulmonary function tests in emphysema. Chest 106:806-813, 1994
46. Stern EJ, Frank MS: CT of the lung in patients with pulmonary emphysema: diagnosis, quantification, and correlation with pathologic and physiologic findings. Am J Radiol 162:791-798, 1994
47. Wiggins J, Strickland B, Turner-Warwick M: Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 84:365-369, 1990
48. European Respiratory Society: Standardized lung function testing: official statement of the European Respiratory Society. Eur Respir J 6 (Suppl 16): 1-100, 1993
49. Snow M, Stein C, Fallat R: Interlaboratory variability of pulmonary function tests. Am Rev Respir Diagn 2:43-45, 1983
50. Kangalee KM. Abboud RT: Interlaboratory and intralaboratory variability in pulmonary function testing: a 13-year study using a normal biologic control. Chest 101:88-92, 1992